Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Diabetes Res Clin Pract. 2017 Jun 12;130:258–265. doi: 10.1016/j.diabres.2017.06.010

Table 1.

Demographic and clinical characteristics of participants ages 12–19 years with cystatin C (adjusted for age, sex and race/ethnicity) from the SEARCH for Diabetes in Youth Study, stratified by diabetes type, and NHANES 2001–2002 without diagnosed diabetes.

Clinical characteristics SEARCH Type 1*
N=977
Mean (SE)
SEARCH Type 2*
N=168
Mean (SE)
NHANES 2001–2002**
N=544
Mean (SE)
Age, years 14.9 (0.07)$& 16.3 (0.17)$# 15.5(0.12)#&
Diabetes Duration 3.6 (0.07)& 2.8 (0.2)# NA
Sex, % Male 51.3& 36.3$# 54.5&
Race/Ethnicity (%) $& $# #&
   White 76.8 19.6 62.8
   Black 9.2 45.8 13.8
   Hispanic 10.2 25.6 16.8
   Other 3.8 8.9 6.6
SBP z-score −0.5 (0.03)& 0.3 (0.08) $# −0.3 (0.07)&
DBP z-score 0.1 (0.03) $& 0.6 (0.07) $# −0.4 (0.07)#&
BMI z-score 0.7 (0.03) $& 2.1 (0.05) $# 0.5(0.06) # &
Fasting glucose, mg/dL 191.7 (2.9) 169.3 (6.8) NA
HbA1c, % 8.5 (0.06) $ 7.9 (0.2) $ 5.2 (0.01) # &
(IFCC units) (69 mmol/mol) (63 mmol/mol) (33 mmol/mol)
Albumin/Creatinine ratio (µg/mg)@ 6.6 (4.4, 12.1) 7.2 (4.3, 18.8)$ 6.3 (4.2, 11.2)&
Adjusted Cystatin C, mg/L^ 0.75 (0.004)$& 0.70 (0.01)$# 0.85 (0.01)#&
*

Restricted to age 12–19, Cystatin C measured, and Type1 or Type 2 Diabetes.

**

Restricted to age 12–19, Cystatin C measured, and non-diabetic; NHANES values reported incorporate the sampling weights for the complex survey design. SBP Systolic blood pressure; DBP Diastolic blood pressure;

@

median (25th, 75th percentiles) -Tests performed on log transformed values as data were not normally distributed;

$

P<0.001 compared with NHANES

#

P<0.001 compared with SEARCH Type 1

&

P<0.001 compared with SEARCH Type 2

^

Adjusted for age, sex, race/ethnicity